We are catalyzing innovation to accelerate a cure for FSHD

Our purpose is to solve FSHD with a focus on all forms of this rare neuromuscular disease. We will do this by removing barriers and accelerating development of novel therapies for FSHD.

Our Plan

Our Approach

SOLVE FSHD is a venture philanthropic organization founded on the generous commitment of $100M USD from the Wilson family. We are part of a larger global FSHD community that has brought us to a place and time where cures for FSHD are possible. As a mission-driven organization, our unique approach is to be a catalyst, making strategic investments through partners in leading academic, biotech and biopharmaceutical organizations. 

We will work with our partners and advisors in the life sciences community to develop a pipeline of new therapies and a cure by 2027. Once we have a SOLVE for FSHD we will continue to support the ongoing needs of this global community.

Funded to Date

We’re focused on funding research and clinical trials, partnering with academics and biotech companies.

Funds Committed: $100 Million

What is FSHD?

Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy in which there is progressive muscle degeneration and muscle weakness. There is currently no treatment or cure.